TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
EOLS

Evolus Inc

Healthcare · Drug Manufacturers - Specialty & Generic

8.30$ +3.3% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet EOLS
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
4.9% 0.3% 47.8% 54.9% 63.3% 61.0% 69.4% 56.6% 59.5% 65.1% 63.3%
4.9% 0.2% 0.0% 54.2% 45.7% 49.1% 56.8% 30.3% 33.2% 37.4% 23.8%
4.9% 0.2% 54.2% 54.0% 51.4% 56.8% 30.3% 33.2% 37.4% 23.8%
47.7% 4.4% 4.6% 5.7% 12.6% 16.2% 20.5% 24.2%
2.7% 1.6% 0.7% 10.6% 5.8% 5.2% 11.9%
2.1% 2.3% 0.5% 1.5%
26.1% 27.4% 13.9% 12.3% 8.8% 10.1% 8.2% 11.9% 11.2% 9.1% 9.4%
69.0% 72.4% 36.8% 32.6% 24.8% 26.4% 19.7% 27.3% 24.9% 21.0% 21.3%
85.2% 109.2% 149.6% 50.9% 67.0% 134.9% 68.2% 89.6% 110.9% 97.6% 110.2%
59.2% 81.7% 139.8% 3.1% 10.2% 86.2% 22.4% 26.1% 25.6% 27.1% 33.3%
56.8% 77.1% 138.8% 0.5% 45.3% 0.5% 0.7% 0.7% 0.7% 1.1%
0.3% 3.7% 0.3% 0.9% 2.4% 4.6% 2.4% 5.0% 2.3% 4.0% 10.3%
9.8% 38.0% 19.4% 27.7% 40.4% 63.7% 52.2% 64.7%
14.8% -9.2% -49.6% 49.1% 33.0% -34.9% 31.8% 10.4% -10.9% 2.4% -10.2%
-57.5% -86.2% -49.6% -71.6% -88.6% -179.9% -164.2% -279.4% -295.8% -262.0% -292.7%
22.9% 24.0% 15.5% 14.2% 11.7% 16.1% 19.3% 31.5% 30.1% 26.7% 28.5%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?